Barclays »

Elicio Therapeutics shares owned by Barclays

Quarter-by-quarter ownership of Elicio Therapeutics (ELTX) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Elicio Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Elicio Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Elicio Therapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2026-06-30 $6.9k 1.8k 3.91

More positions owned by Barclays

STATE STR SPDR S&ampP 500 ETF T Fund (SPY)
Ishares Tr Opt Call Option (EEM)
Microsoft Corp Opt Call Option (MSFT)
Invesco Qqq Tr Fund (QQQ)
Ishares Tr Fund (IWM)
Nvidia Corporation Opt Call Option (NVDA)
Micron Technology (MU)
Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Amazon Opt Put Option (AMZN)
Vaneck Etf Trust Opt Put Option (SMH)
Tesla Motors (TSLA)
Advanced Micro Devices Opt Put Option (AMD)
Broadcom Opt Put Option (AVGO)
Ishares Tr Opt Call Option (HYG)

View all positions for Barclays

Top funds holding Elicio Therapeutics

Knoll Capital Management
BlackRock
Caption Management
Vanguard Capital Management
Ikarian Capital
Geode Capital Management
Susquehanna International
Diadema Partners
Toronto-Dominion Bank
Jane Street
Citadel Advisors
Northern Trust
Boothbay Fund Management
Vanguard Portfolio Management
Vanguard Fiduciary Trust

View all funds holding Elicio Therapeutics